Sorted By:

Relevance


PhRMA Statement on the ITC Report on India

PhRMA  |  Press Release

(December 22, 2014) — Pharmaceutical Research and Manufacturers of America (PhRMA) Deputy President, Mark Grayson issued the following statement: "PhRMA welcomes today’s release of the U.S.
https://www.phrma.org/press-release/phrma-statement-on-the-itc-report-on-india

PhRMA Statement on House Health Care Reform Bill

PhRMA  |  Press Release

(October 29, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson released the following statement regarding the House health care reform bill: “Our top priority is to help ensure that a comprehensive health care reform bill gets to the President's desk this year so that millions of uninsured Americans have access to high-quality, affordable health care coverage and.facebook.com/sharer.php?
https://www.phrma.org/press-release/phrma-statement-on-house-health-care-reform-bill

Brian Toohey to Lead International Advocacy at PhRMA

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/brian-toohey-to-lead-international-advocacy-at-phrma

PhRMA Statement on FDA Communications Hearing

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org   www.FromHopetoCures.org  www.Facebook.com/PhRMA  www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-statement-on-fda-communications-hearing

PhRMA Statement on the Health Reform Dialogue

PhRMA  |  Press Release

(March 27, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement today regarding the Health Reform Dialogue: “PhRMA’s message throughout the healthcare reform debate is one that has been echoed by many other stakeholders, including the diverse group of organizations participating in the Health Reform Dialogue (HRD): all Americans should be able to access high-quality and affordable healthcare coverage.
https://www.phrma.org/press-release/phrma-statement-on-the-health-reform-dialogue

PhRMA Statement on Patent Reform - 2011

PhRMA  |  Press Release

(June 23, 2011) — The Pharmaceutical Research and Manufacturers of America Deputy Vice President Karl Uhlendorf today released the following statement regarding patent reform: "PhRMA believes that patent reform legislation offers the opportunity to stimulate the economy, encourage innovation, promote patent certainty and provide for a strong Patent and Trademark Office (PTO).
https://www.phrma.org/press-release/phrma-statement-on-patent-reform-2011

CSRxP Proposals Would Undermine Competitive Market, Harm Patients and Innovation

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/csrxp-proposals-would-undermine-competitive-market-harm-patients-and-innovation

PhRMA Statement on PCORI Nominees

PhRMA  |  Press Release

Washington, D.C. (June 30, 2010) – The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement about PhRMA’s nominees for the Patient-Centered Outcomes Research Institute’s Board: “The recently enacted health care reform law created a Pa...
https://www.phrma.org/press-release/phrma-statement-on-pcori-nominees

PhRMA Statement on Authorized Generics

PhRMA  |  Press Release

Washington, D.C. (June 25, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding the Federal Trade Commission’s interim report on authorized generics: “We agree with the Federal...
https://www.phrma.org/press-release/phrma-statement-on-authorized-generics

PhRMA Statement on Patent Settlements

PhRMA  |  Press Release

Washington, D.C. (June 28, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding patent settlement language in the House war supplemental bill: “Patent settlements are a vital a...
https://www.phrma.org/press-release/phrma-statement-on-patent-settlements1

PhRMA Statement on Intellectual Property

PhRMA  |  Press Release

Washington, D.C. (February 16, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy .google.com/news?q=Billy+Tauzin&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&hl=en&...
https://www.phrma.org/press-release/phrma-statement-on-intellectual-property

PhRMA Commends House of Representatives

PhRMA  |  Press Release

Washington, D.C. (December 5, 2013) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matt Bennett issued the following statement on H.R. 3309, the Innovation Act, as passed by the U.S. House of Representatives today:  “PhRMA commends the...
https://www.phrma.org/press-release/phrma-commends-house-of-representatives

PhRMA Statement on Time Magazine Article

PhRMA  |  Press Release

The ‘proposals’ in the Time Magazine story to lower medicine-related health costs are misguided, would impede and even reverse the health and economic progress made by medicines and undermine the ability to invest in cutting-edge science that yields better care and economic growth.”
https://www.phrma.org/press-release/phrma-statement-on-time-magazine-article

Patient Advocates, Researchers Honored at 2014 Research & Hope Awards

PhRMA  |  Press Release

To learn more about the more than 40 medicines and vaccines for HIV infection currently in development as well as innovation in the disease’s treatment, view our recent press release here.   
https://www.phrma.org/press-release/patient-advocates-researchers-honored-at-2014-research-and-hope-awards

More Than 400 Innovative Medicines in Development For Top Chronic Diseases Affecting Older Americans

PhRMA  |  Press Release

Among the potential medicines listed in the report are:   A treatment that aims to prevent or reverse progression of Alzheimer’s disease by using a human monoclonal antibody specifically designed to draw beta amyloid protein away from the brain through the blood system.
https://www.phrma.org/press-release/more-than-400-innovative-medicines-in-development-for-top-chronic-diseases-affecting-older-americans

More than 100 New Medicines in Development to Treat Mental and Addictive Disorders

PhRMA  |  Press Release

In addition to information on some of the medicines in the pipeline, the new report delves into challenges unique to the research and development of mental health treatments, collaborative research partnerships that are helping advance science, early scientific discoveries that are raising our understanding of mental health conditions, the importance of adherence to medicines for mental health disorders, and comprehensive facts about mental health in the United States.
https://www.phrma.org/press-release/more-than-100-new-medicines-in-development-to-treat-mental-and-addictive-disorders

Nearly 200 New Medicines in Development for Diabetes

PhRMA  |  Press Release

A new public-private partnership involving the National Institutes of Health (NIH), 10 biopharmaceutical companies, PhRMA and several non-profit disease foundations aims to transform the current model for developing new diagnostics and treatments for certain diseases.
https://www.phrma.org/press-release/nearly-200-new-medicines-in-development-for-diabetes

PhRMA Appoints Amy Jackson as New Japan Representative

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-appoints-amy-jackson-as-new-japan-representative

PhRMA Brings Scientists to Capitol Hill

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-brings-scientists-to-capitol-hill

PhRMA Statement on New FDA Initiative

PhRMA  |  Press Release

(May 11, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson today released the following statement: “America’s pharmaceutical research and biotechnology companies are committed to communicating truthful, scientifically accurate information in all direct-to-consumer (DTC) advertising and interactions with healthcare professionals.
https://www.phrma.org/press-release/phrma-statement-on-new-fda-initiative

PhRMA Statement on Health Care Reform

PhRMA  |  Press Release

(January 20, 2010) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today released the following statement on health care reform: “We continue to believe that all Americans should have access to high-quality, affordable health care coverage and services.
https://www.phrma.org/press-release/phrma-statement-on-health-care-reform

PhRMA Supports American Medicine Chest Challenge

PhRMA  |  Press Release

Washington, D.C. (October 4, 2010) — The Pharmaceutical Research and Manufacturers of America (PhRMA) announces today its founding sponsorship of the American Medicine Chest Challenge (AMCC). The AMCC is a national drug d...
https://www.phrma.org/press-release/phrma-supports-american-medicine-chest-challenge

PhRMA Statement on Institute of Medicine Report

PhRMA  |  Press Release

Washington, D.C. (April 28, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement regarding the Institute of Medicine’s (IOM) report on interactions among pharmaceutical, medical device and biotechnol...
https://www.phrma.org/press-release/phrma-statement-on-institute-of-medicine-report

PhRMA Announces Promotions of Key Federal Affairs Staff

PhRMA  |  Press Release

Washington, D.C. (January 22, 2009) — Underscoring a commitment to working with all stakeholders and policymakers to promote health care opportunities for America’s patients and to maintain the innovation that leads to the medicines of the future, the Pharmaceutical Research and ...
https://www.phrma.org/press-release/phrma-announces-promotions-of-key-federal-affairs-staff

PhRMA Statement on Biosimilars Regulatory Pathway

PhRMA  |  Press Release

Washington, D.C. (August 4, 2011) —Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President David E. Wheadon today issued the following statement on the FDA’s ongoing efforts to develop a user fee program and regulatory pathway for biosimilars products:...
https://www.phrma.org/press-release/phrma-statement-on-biosimilars-regulatory-pathway

You have reviewed the first 200 results out of 880. Each page contains 25 results. You're on page 8.

prev 7 8 9 10 11 12 next